Scientist to Watch

» developmental biology, infectious disease and cancer

Most Recent

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39


image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44


image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34


image: Frank Bradke: Privy to Axon Growth

Frank Bradke: Privy to Axon Growth

By | December 1, 2011

Full Professor and Senior Research Group Leader, German Center for Neurodegenerative Diseases. Age: 42


image: Harmit Malik: Viral Historian

Harmit Malik: Viral Historian

By | July 1, 2011

Member, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Age: 38


image: Ted Cohen: Travelling for TB

Ted Cohen: Travelling for TB

By | March 1, 2011

Assistant professor, Department of Epidemiology, Harvard School of Public Health. Age: 37


image: Jeremy Reiter: Hunting for Cilia

Jeremy Reiter: Hunting for Cilia

By | January 1, 2011

Assistant professor of biochemistry, University of California, San Francisco. Age: 39


Popular Now

  1. Rethinking the Rise of Mammals
    Daily News Rethinking the Rise of Mammals

    Mammals diversified 30 million years later than previously estimated, according to a new analysis of an ancient fossil.

  2. Wiping Out Gut Bugs Stops Obesity
  3. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  4. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

Horizon Discovery
Horizon Discovery
Life Technologies